Last update 11 Jul 2024
Salubris Biotherapeutics, Inc.

Salubris Biotherapeutics, Inc.

Startups
|
Holding Company|
2016|
Maryland, United States
|
10-50
|

Overview

Basic Info

Introduction
Established in August 2016, SalubrisBio is a clinical-stage biotechnology company with a primary focus on the discovery and development of intricate biologics tailored for cardiovascular, oncology, and neurodegenerative diseases. As a wholly-owned subsidiary of the China-based pharmaceutical company Shenzhen Salubris Pharmaceuticals Co. Ltd., SalubrisBio is headquartered in the United States. It embodies the commitment of Shenzhen Salubris Pharmaceuticals to innovation and global market expansion, while adhering to the fundamental philosophy of creating therapeutics for large patient populations with significant unmet needs.

Tags

Neoplasms
Other Diseases
Endocrinology and Metabolic Disease
Fusion protein
Antibody drug conjugate (ADC)
Antibody fusion proteins

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Top 5 Drug TypeCount
Fusion protein2
Antibody drug conjugate (ADC)1
Antibody fusion proteins1

Corporation Tree

Boost your research with our corporation tree data.
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 24 Jul 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
2
2
Phase 2 Clinical
Login to view more data

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free